MDD POC Study GSK372475 Subjects Depressive Disease

NCT00420641 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

492

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder

Interventions

DRUG: GSK372475
DRUG: Paroxetine
OTHER: Placebo

Sponsor

GlaxoSmithKline